Modeling the safe minimum frequency of molecular monitoring for CML patients attempting treatment-free remission

被引：24

作者：

Shanmuganathan, Naranie ^{[1
,2
,3
,4
,5
,6
,7
]}

Braley, Jodi A. ^{[7
]}

Yong, Agnes S. M. ^{[4
,6
]}

Hiwase, Devendra K. ^{[1
,2
,4
,6
]}

Yeung, David T. ^{[1
,2
,4
,5
,6
]}

Ross, David M. ^{[1
,2
,3
,4
,6
,8
]}

Hughes, Timothy P. ^{[1
,2
,4
,5
,6
]}

Branford, Susan ^{[3
,5
,7
,9
]}

机构：

[1] Royal Adelaide Hosp, Dept Haematol, Port Rd, Adelaide, SA 5000, Australia

[2] SA Pathol, Dept Haematol, Adelaide, SA, Australia

[3] SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia

[4] South Australian Hlth & Med Res Inst, Canc Theme, Adelaide, SA, Australia

[5] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia

[6] Univ Adelaide, Sch Med, Adelaide, SA, Australia

[7] SA Pathol, Dept Genet & Mol Pathol, Adelaide, SA, Australia

[8] Flinders Univ & Med Ctr, Dept Haematol, Adelaide, SA, Australia

[9] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia

来源：

BLOOD | 2019年 / 134卷 / 01期

基金：

英国医学研究理事会;

关键词：

CHRONIC MYELOID-LEUKEMIA; IMATINIB; NILOTINIB; DISCONTINUATION; BCR-ABL1; DYNAMICS;

D O I：

10.1182/blood.2019000120

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：85 / 89

页数：5

共 13 条

[1] Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials [J].

Branford, Susan ;

Fletcher, Linda ;

Cross, Nicholas C. P. ;

Mueller, Martin C. ;

Hochhaus, Andreas ;

Kim, Dong-Wook ;

Radich, Jerald P. ;

Saglio, Giuseppe ;

Pane, Fabrizio ;

Kamel-Reid, Suzanne ;

Wang, Y. Lynn ;

Press, Richard D. ;

Lynch, Kevin ;

Rudzki, Zbigniew ;

Goldman, John M. ;

Hughes, Timothy .

BLOOD, 2008, 112 (08) :3330-3338

[2] Prognosis for patients with CML and >10% BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 decline [J].

Branford, Susan ;

Yeung, David T. ;

Parker, Wendy T. ;

Roberts, Nicola D. ;

Purins, Leanne ;

Braley, Jodi A. ;

Altamura, Haley K. ;

Yeoman, Alexandra L. ;

Georgievski, Jasmina ;

Jamison, Bronte A. ;

Phillis, Stuart ;

Donaldson, Zoe ;

Leong, Mary ;

Fletcher, Linda ;

Seymour, John F. ;

Grigg, Andrew P. ;

Ross, David M. ;

Hughes, Timothy P. .

BLOOD, 2014, 124 (04) :511-518

[3] BCR-ABL1 doubling times more reliably assess the dynamics of CML relapse compared with the BCR-ABL1 fold rise: implications for monitoring and management [J].

Branford, Susan ;

Yeung, David T. ;

Prime, Jodi A. ;

Choi, Soo-Young ;

Bang, Ju-hee ;

Park, Jin Eok ;

Kim, Dong-Wook ;

Ross, David M. ;

Hughes, Timothy P. .

BLOOD, 2012, 119 (18) :4264-4271

[4] Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study [J].

Hochhaus, A. ;

Masszi, T. ;

Giles, F. J. ;

Radich, J. P. ;

Ross, D. M. ;

Gomez Casares, M. T. ;

Hellmann, A. ;

Stentoft, J. ;

Conneally, E. ;

Garcia-Gutierrez, V. ;

Gattermann, N. ;

Wiktor-Jedrzejczak, W. ;

le Coutre, P. D. ;

Martino, B. ;

Saussele, S. ;

Menssen, H. D. ;

Deng, W. ;

Krunic, N. ;

Bedoucha, V. ;

Saglio, G. .

LEUKEMIA, 2017, 31 (07) :1525-1531

[5] Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase [J].

Mahon, Francois-Xavier ;

Boquimpani, Carla ;

Kim, Dong-Wook ;

Benyamini, Noam ;

Clementino, Nelma Cristina D. ;

Shuvaev, Vasily ;

Ailawadhi, Sikander ;

Lipton, Jeffrey Howard ;

Turkina, Anna G. ;

De Paz, Raquel ;

Moiraghi, Beatriz ;

Nicolini, Franck E. ;

Dengler, Jolanta ;

Sacha, Tomasz ;

Takahashi, Naoto ;

Fellague-Chebra, Rafik ;

Acharya, Sandip ;

Wong, Stephane ;

Jin, Yu ;

Hughes, Timothy P. .

ANNALS OF INTERNAL MEDICINE, 2018, 168 (07) :461-+

[6] Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial [J].

Mahon, Francois-Xavier ;

Rea, Delphine ;

Guilhot, Joelle ;

Guilhot, Francois ;

Huguet, Francoise ;

Nicolini, Franck ;

Legros, Laurence ;

Charbonnier, Aude ;

Guerci, Agnes ;

Varet, Bruno ;

Etienne, Gabriel ;

Reiffers, Josy ;

Rousselot, Philippe .

LANCET ONCOLOGY, 2010, 11 (11) :1029-1035

[7] Dynamics of chronic myeloid leukaemia [J].

Michor, F ;

Hughes, TP ;

Iwasa, Y ;

Branford, S ;

Shah, NP ;

Sawyers, CL ;

Nowak, MA .

NATURE, 2005, 435 (7046) :1267-1270

[8] Chronic Myeloid Leukemia, Version 1.2019 Clinical Practice Guidelines in Oncology [J].

Radich, Jerald P. ;

Deininger, Michael ;

Abboud, Camille N. ;

Altman, Jessica K. ;

Berman, Ellin ;

Bhatia, Ravi ;

Bhatnagar, Bhavana ;

Curtin, Peter ;

DeAngelo, Daniel J. ;

Gotlib, Jason ;

Hobbs, Gabriela ;

Jagasia, Madan ;

Kantarjian, Hagop M. ;

Maness, Lori ;

Metheny, Leland ;

Moore, Joseph O. ;

Pallera, Arnel ;

Pancari, Philip ;

Patnaik, Mrinal ;

Purev, Enkhtsetseg ;

Rose, Michal G. ;

Shah, Neil P. ;

Smith, B. Douglas ;

Snyder, David S. ;

Sweet, Kendra L. ;

Talpaz, Moshe ;

Thompson, James ;

Yang, David T. ;

Gregory, Kristina M. ;

Sundar, Hema .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (09) :1108-1135

[9] Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study [J].

Rea, Delphine ;

Nicolini, Franck E. ;

Tulliez, Michel ;

Guilhot, Francois ;

Guilhot, Joelle ;

Guerci-Bresler, Agnes ;

Gardembas, Martine ;

Coiteux, Valerie ;

Guillerm, Gaelle ;

Legros, Laurence ;

Etienne, Gabriel ;

Pignon, Jean-Michel ;

Villemagne, Bruno ;

Escoffre-Barbe, Martine ;

Ianotto, Jean-Christophe ;

Charbonnier, Aude ;

Johnson-Ansah, Hyacinthe ;

Noel, Marie-Pierre ;

Rousselot, Philippe ;

Mahon, Francois-Xavier .

BLOOD, 2017, 129 (07) :846-854

[10] Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study [J].

Ross, David M. ;

Branford, Susan ;

Seymour, John F. ;

Schwarer, Anthony P. ;

Arthur, Christopher ;

Yeung, David T. ;

Phuong Dang ;

Goyne, Jarrad M. ;

Slader, Cassandra ;

Filshie, Robin J. ;

Mills, Anthony K. ;

Melo, Junia V. ;

White, Deborah L. ;

Grigg, Andrew P. ;

Hughes, Timothy P. .

BLOOD, 2013, 122 (04) :515-522

← 1 2 →